XPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene’s Commercial Presence in APAC
Press Releases

XPOVIO® (selinexor) Approved for Commercialization in Indonesia, Further Expanding Antengene’s Commercial Presence in APAC

- XPOVIO® is the first and only approved XPO1 inhibitor in Indonesia.

avatar profile Olean Times Herald

Olean Times Herald


Local & Social